| pubmed-article:2282691 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2282691 | lifeskim:mentions | umls-concept:C0459385 | lld:lifeskim |
| pubmed-article:2282691 | lifeskim:mentions | umls-concept:C0010289 | lld:lifeskim |
| pubmed-article:2282691 | lifeskim:mentions | umls-concept:C0010957 | lld:lifeskim |
| pubmed-article:2282691 | lifeskim:mentions | umls-concept:C0560150 | lld:lifeskim |
| pubmed-article:2282691 | lifeskim:mentions | umls-concept:C1446561 | lld:lifeskim |
| pubmed-article:2282691 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
| pubmed-article:2282691 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2282691 | pubmed:dateCreated | 1991-3-18 | lld:pubmed |
| pubmed-article:2282691 | pubmed:abstractText | A new two-site immunoenzymometric method using monoclonal antibodies was developed for measuring CK-BB mass concentrations in cerebrospinal fluid (CSF). Within- and between-assay coefficient of variation values for the method varied between 6 and 9%. Assay results are not affected by presence of sulfate and sialic acid groups on the enzyme. In comparison to catalytic activity measurements, a steady decline in the enzyme's specific activity was observed after acute head trauma. Repetitive measurements of CK-BB mass concentration in cerebrospinal fluid during the first 24 h after trauma enabled the estimation of brain lesion size. Clinical outcome of acute head trauma patients evaluated by Glasglow Outcome Scale, correlated well with cumulative CK-BB release after trauma. Also in neonates, CK-BB determinations in CSF correlated well with clinical findings. | lld:pubmed |
| pubmed-article:2282691 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2282691 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2282691 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2282691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2282691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2282691 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2282691 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2282691 | pubmed:issn | 0009-8981 | lld:pubmed |
| pubmed-article:2282691 | pubmed:author | pubmed-author:De PraeterCC | lld:pubmed |
| pubmed-article:2282691 | pubmed:author | pubmed-author:DelangheJ RJR | lld:pubmed |
| pubmed-article:2282691 | pubmed:author | pubmed-author:De BuyzereM... | lld:pubmed |
| pubmed-article:2282691 | pubmed:author | pubmed-author:MartinoJ AJA | lld:pubmed |
| pubmed-article:2282691 | pubmed:author | pubmed-author:De WinterH... | lld:pubmed |
| pubmed-article:2282691 | pubmed:author | pubmed-author:CamaertJ JJJ | lld:pubmed |
| pubmed-article:2282691 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2282691 | pubmed:day | 14 | lld:pubmed |
| pubmed-article:2282691 | pubmed:volume | 193 | lld:pubmed |
| pubmed-article:2282691 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2282691 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2282691 | pubmed:pagination | 125-35 | lld:pubmed |
| pubmed-article:2282691 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:meshHeading | pubmed-meshheading:2282691-... | lld:pubmed |
| pubmed-article:2282691 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2282691 | pubmed:articleTitle | Mass concentration measurements of creatine kinase BB isoenzyme as an index of brain tissue damage. | lld:pubmed |
| pubmed-article:2282691 | pubmed:affiliation | Department of Clinical Chemistry, University Hospital, Gent, Belgium. | lld:pubmed |
| pubmed-article:2282691 | pubmed:publicationType | Journal Article | lld:pubmed |
